On September 23, 2026, HENGRUI PHARMA (01276) executed a share repurchase, investing RMB 11.3723 million to buy back 250,000 A-shares. The buyback price ranged between RMB 45.42 and RMB 45.54 per share, as disclosed in a recent company announcement.

The repurchase reflects the company's move to enhance shareholder value and signal confidence in its stock performance.